InVivo Therapeutics Corporation (NVIV) Appoints Christopher McNulty As Vice President, Business Development & Investor Relations
7/1/2014 12:01:57 PM
InVivo Therapeutics Holdings Corp. (NVIV) today announced that the role of Christopher McNulty has been expanded to include investor relations and corporate communications. Mr. McNulty has been serving as Vice President, Business Development, and will continue to lead efforts in that area.
Help employers find you! Check out all the jobs and post your resume.
comments powered by